Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development. I: Interspecies Allometric Scaling

Author： Cosson Valérie F.   Fuseau Eliane   Efthymiopoulos Constantin   Bye Alan  

Publisher： Springer Publishing Company

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.25, Iss.2, 1997-04, pp. : 149-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Obesity and Allometric Scaling of Pharmacokinetics

By Eleveld Douglas J.   Proost Johannes H.   Absalom Anthony R.   Struys Michel M.R.F.  

Clinical Pharmacokinetics, Vol. 50, Iss. 11, 2011-11 ,pp. : 751-753

Adis International

Access to resources Recommend Favorite

The Authors' Reply: Obesity and Allometric Scaling of Pharmacokinetics

By Diepstraten Jeroen   Knibbe Catherijne A.J.  

Clinical Pharmacokinetics, Vol. 50, Iss. 11, 2011-11 ,pp. : 755-756

Adis International

Access to resources Recommend Favorite

Prediction of Hepatic Metabolic Clearance Based on Interspecies Allometric Scaling Techniques and In Vitro - In Vivo Correlations

By Lavé T.  

Clinical Pharmacokinetics, Vol. 36, Iss. 3, 1999-03 ,pp. : 211-231

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Intranasal Sumatriptan

By Fuseau E.  

Clinical Pharmacokinetics, Vol. 41, Iss. 11, 2002-01 ,pp. : 801-811

Adis International

Access to resources Recommend Favorite

Allometric or Lean Body Mass Scaling of Propofol Pharmacokinetics: Towards Simplifying Parameter Sets for Target-Controlled Infusions

By >  

Clinical Pharmacokinetics, Vol. 51, Iss. 3, 2012-03 ,pp. : 137-145

Adis International

Access to resources Recommend Favorite